Therefore, miR-29a-3p-overexpressing exosomes can potentially support anti-vascular endothelial growth factor (VEGF) therapy and limit the blood supply, consequently restricting the growth of the tumor [32]. The gene discussed is VEGFA; the disease is neoplasm.